Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy.

Journal of Neuro-oncology
Kevin Yijun FanAlan McVey Nichol

Abstract

This study aimed to investigate whether systemic therapy (ST) use surrounding radiation therapy (RT) predicts overall survival (OS) after RT for patients with brain metastases (BMs). Provincial RT and pharmacy databases were used to review all adult patients in British Columbia, Canada, who received a first course of RT for BMs between 2012 and 2016 (n = 3095). Multivariate analysis on a randomly selected subset was used to develop an OS nomogram. In comparison to the 2096 non-recipients of ST after RT, the median OS of the 999 recipients of ST after RT was 5.0 (95% Confidence interval (CI) 4.1-6.0) months longer (p < 0.0001). Some types of ST after RT were independently predictive of OS: targeted therapy (hazard ratio (HR) 0.42, CI 0.37-0.48), hormone therapy (HR 0.45, CI 0.36-0.55), cytotoxic chemotherapy (HR 0.71, CI 0.64-0.79), and immunotherapy (HR 0.64, CI 0.37-1.06). Patients who discontinued ST after RT had 0.9 (CI 0.3-1.4) months shorter median OS than patients who received no ST before or after RT (p < 0.0001). In the multivariate analysis of the 220-patient subset, established prognostic variables (extracranial disease, performance status, age, cancer diagnosis, and number of BMs), and the novel variables "ST before ...Continue Reading

References

Feb 22, 1990·The New England Journal of Medicine·R A PatchellB Young
Mar 1, 1997·International Journal of Radiation Oncology, Biology, Physics·L GasparR Byhardt
Nov 11, 1998·JAMA : the Journal of the American Medical Association·R A PatchellB Young
Mar 31, 1999·International Journal of Radiation Oncology, Biology, Physics·F J LagerwaardP I Schmitz
Mar 22, 2000·International Journal of Radiation Oncology, Biology, Physics·E WeltmanD B Wajsbrot
Sep 1, 2004·International Journal of Radiation Oncology, Biology, Physics·José LorenzoniMarc Levivier
Oct 13, 2007·International Journal of Radiation Oncology, Biology, Physics·Paul W SperdutoWalter Curran
Apr 23, 2008·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Dirk RadesSteven E Schild
Nov 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin KocherRolf-Peter Mueller
Mar 30, 2012·The Lancet Oncology·Kim MargolinF Stephen Hodi
May 1, 2012·Neuro-oncology·Jill S Barnholtz-SloanMichael W Kattan
Jul 20, 2012·Continuum : Lifelong Learning in Neurology·Christine Lu-Emerson, April F Eichler
Jul 17, 2015·JAMA Oncology·Hidefumi AoyamaUNKNOWN Japanese Radiation Oncology Study Group 99-1 (JROSG 99-1) Investigators
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Anna S BerghoffManmeet S Ahluwalia
Feb 27, 2017·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jaap D ZindlerPhilippe Lambin
Nov 21, 2017·The New England Journal of Medicine·Jean-Charles SoriaUNKNOWN FLAURA Investigators
Dec 23, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul D BrownVinai Gondi
Mar 7, 2018·Trends in Cancer·Manuel ValienteRiccardo Soffietti
Jun 6, 2019·The New England Journal of Medicine·Caroline RobertGeorgina V Long
Nov 30, 2019·Nature Reviews. Cancer·Adrienne BoireManuel Valiente
Dec 10, 2019·Journal of Translational Medicine·Zhixian YaoZhihong Liu
Dec 12, 2019·The New England Journal of Medicine·Rashmi K MurthyEric P Winer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.